View Older Stories View More Recent Stories
-
TETRA Technologies Inc. (TTI) PT Lowered to $2.50 at RBC Capital
-
Targa Resources (TRGP) PT Lowered to $51 at RBC Capital
-
Southwestern Energy (SWN) PT Lowered to $3.50 at RBC Capital
-
Rayonier (RYN) PT Lowered to $28 at RBC Capital
-
Q2 Holdings (QTWO) PT Raised to $94 at RBC Capital
-
Puma Biotechnology (PBYI) PT Raised to $23 at RBC Capital
-
Plains All American (PAA) PT Lowered to $26 at RBC Capital
-
RBC Capital Reiterates Outperform Rating on Phoenix Group Holdings (PHXXF)
-
Paylocity Holding (PCTY) PT Raised to $107 at RBC Capital
-
Osmotica (OSMT) PT Lowered to $8 at RBC Capital
-
RBC Capital Reiterates Top Pick Rating on Cineworld Group Plc. (CNWGY)
-
RBC Capital Reiterates Outperform Rating on bpost SA (BPOSY)
-
RBC Capital Reiterates Sector Perform Rating on OC Oerlikon Corp AG (OERLF)
-
Oasis Petroleum (OAS) PT Lowered to $8 at RBC Capital
-
Puma SE (PUM:GR) (PMMAF) PT Raised to EUR48 at RBC Capital
-
NICE Systems Ltd (NICE) PT Raised to $159 at RBC Capital
-
Hastings Group Holdings Plc. (HSTG:LN) PT Lowered to GBp190 at RBC Capital
-
Mindray Medical (MR) PT Lowered to $17 at RBC Capital
-
Adidas AG (ADS:GR) (ADDYY) PT Lowered to EUR300 at RBC Capital
-
LHC Group (LHCG) PT Raised to $135 at RBC Capital
-
RBC Capital Double Upgrades MorphoSys AG (MOR:GR) (MPSYF) to Outperform
-
Installed Building Products (IBP) PT Raised to $59 at RBC Capital
-
GrafTech (EAF) PT Raised to $18 at RBC Capital
-
DXC Technology (DXC) PT Lowered to $67 at RBC Capital
-
Covia Holdings Corp (CVIA) PT Lowered to $3 at RBC Capital
-
Cision Ltd (CISN) PT Lowered to $14 at RBC Capital
-
Americold Realty Trust (COLD) PT Raised to $38 at RBC Capital
-
American International Group (AIG) PT Raised to $68 at RBC Capital
-
Akebia Therapeutics (AKBA) PT Lowered to $8 at RBC Capital
-
Aimmune Therapeutics (AIMT) PT Lowered to $50 at RBC Capital
-
UPDATE: RBC Capital Downgrades Venator Materials (VNTR) to Sector Perform
-
UPDATE: RBC Capital Downgrades Chemours (CC) to Sector Perform
-
UPDATE: RBC Capital Upgrades FMC Corp. (FMC) to Outperform
-
UPDATE: RBC Capital Upgrades Corteva Inc. (CTVA) to Outperform
-
Sarepta says adverse event report for DMD gene therapy erroneously submitted
-
Magellan Midstream Prices $500 Million Debt Offering Due 2050
-
New Residential Announces Pricing of Public Offering of Preferred Stock
-
EPR Properties Prices $500.0 Million of 3.750% Senior Notes due 2029
-
FDA Adverse Event May Not Be 'Major Showstopper' for Sarepta Therapeutics (SRPT) Program - RBC
-
U.S. small-cap stocks under renewed threat from tariffs
-
TripAdvisor (TRIP) PT Lowered to $50 at RBC Capital
-
National and MBIA Insurance File Lawsuit Against Wall Street Banks for Misconduct as Underwriters in Puerto Rico's Fiscal Crisis
-
New Residential Launches Public Offering of Preferred Stock
-
Shell Midstream Partners, L.P. (SHLX) PT Raised to $20 at RBC Capital
-
Select Energy Services (WTTR) PT Lowered to $10 at RBC Capital
-
Sarepta Therapeutics (SRPT) PT Lowered to $218 at RBC Capital
-
Roku Inc. (ROKU) PT Raised to $107 at RBC Capital
-
QTS Realty Trust (QTS) PT Raised to $52 at RBC Capital
-
Canada dollar outlook brightens with stable domestic economy: Reuters poll
-
Proteostasis Therapeutics (PTI) PT Lowered to $8 at RBC Capital
